A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA
Clinical trial NCT03770624 · UNKNOWN
Trial details
- NCT number
- NCT03770624
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2019-03-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.